JUI-MAN HSIEH: Open Payments
NPI 1972995157 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 28 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $164 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $352 |
| Novartis Pharmaceuticals Corporation | 10 | $197 |
| Amgen Inc. | 3 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| PFIZER INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: VERQUVO, LEQVIO, Repatha, Kerendia, ELIQUIS, SHINGRIX.
Industry payments across CA — which companies pay providers there.
